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The Role of Toll-Like Receptor 4 in the Progression of Keloids
Madison Brandes, Nishi Srivastava, PhD, and Neda Nikbakht, MD, PhD*
(*) indicates primary project advisor
Keloids are highly prevalent in the population and their pathogenesis is largely unknown. T-cell
lymphoma research shows that toll like receptor-4 (TLR-4) is highly expressed on CD206+
immunosuppressive macrophages and is implicated in maintaining the tumor microenvironment.
Additionally, fibronectin, specifically extra domain A (EDA), is highly expressed and is associated
with immunosuppression via the TLR-4 pathway. Assuming that keloids mimic the tumor
microenvironment, we hypothesize that TLR-4 is implicated in the pathogenesis of keloids. Using
keloid tissue samples and normal breast tissue as a control, immunohistochemistry was performed
to observe the presence and co-localization of these markers. Three antibodies were used to
examine co-localization of CD-206 with TLR-4 and CD-206 with EDA to determine if these three
components were localized to the same region in the keloid tissue. The secondary antibodies were
immunofluorescent, and the tissue was analyzed using electron microscopy. Upon analysis, it was
found that in keloid tissue CD-206 and TLR-4 were co-localized. To further support the
hypothesis, it was found that CD-206 and EDA were also co-localized. In the control group, there
was no evidence of co-localization of CD-206 with TLR-4 or with EDA. These findings support
the overall hypothesis that TLR-4 is involved in the pathogenesis of keloids. Discovering that CD206 co-localizes with both TLR-4 and EDA indicates that these three molecules interact to help
form the tumor microenvironment needed to support keloid formation. Knowing this information,
studies can begin to look into possible immunological targets for keloid treatment that access this
immunosuppressive pathway.

